Cancer patients experiencing a deep sense of loneliness and depression during the pandemic

Loneliness and social isolation have been significant problems for the general population during the COVID-19 pandemic, but for cancer patients these issues were particularly acute, likely due to isolation and social distancing, according to a new UCSF study.

The study, which is the first to evaluate loneliness, anxiety, depression, fatigue and other symptoms in a single group of patients, is published in Cancer, a peer-reviewed journal of the American Cancer Society.

We found that oncology patients were experiencing a deep sense of loneliness. For these patients, the burden of their symptoms is extremely high, and oncology clinicians can suggest a number of strategies to help them. Patients should be encouraged to maintain contact with family and friends, and structure their daily routines when possible, through outdoor activities for example, as well as to maintain a healthy diet and sufficient sleep. These suggestions might mitigate some of the negative effects of loneliness."

Christine Miaskowski, RN, PhD, First author, Professor in the UCSF School of Nursing

The COVID-19 pandemic brought to the forefront a pervasive sense of loneliness in the lay population, but the effects have not been well-studied in oncology patients. The new survey, administered in late May 2020, evaluated the severity of loneliness, social isolation and related symptoms - such as anxiety, depression, fatigue, sleep disturbance, cognitive dysfunction and pain - in a sample of 606 oncology patients.

Altogether, 53 percent were found to be in the lonely group, which was higher than the range reported prior to the pandemic (32 percent - 47 percent). About a third had moderately high degrees of loneliness, and 5.3 percent reported high levels of depression.

The lonely group was significantly more likely to be younger than the non-lonely group and less likely to be married or partnered. They also had a higher number of comorbidities and were more likely to report a diagnosis of depression and back pain.

Older cancer patients reported lower levels of loneliness, while patients 50 to 59 reported higher levels. The researchers believe older adults adapted their need for social contact to available opportunities.

Lower levels of household income were associated with higher levels of loneliness. The authors suggest that people at higher incomes have "more opportunities to engage in social activities and reciprocate in social relationships."

Nearly 83 percent of the patients in the lonely group suffered from breast cancer, a third were currently in cancer treatment and a quarter had metastatic disease. Nearly 92 percent of the participants were female - as a result, no conclusions could be drawn about sex differences, the authors said.

Primarily, the participants were White, well-educated, and had an annual income exceeding $60,000. As such, the authors said, their findings may not fit all patients with cancer, and symptoms could be higher in patients who are socioeconomically disadvantaged.

Source:
Journal reference:

Miaskowski, C., et al. (2021) Loneliness and symptom burden in oncology patients during the COVID‐19 pandemic. Cancer. doi.org/10.1002/cncr.33603.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New therapeutic target overcomes ovarian cancer immunotherapy resistance